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Background.— The prevalence of coronary ﬁstulas is poorly known
in the pediatric population. However complications are potentially
serious as: heart failure, sudden death, arrhythmias, and endocardi-
tis. In adults, transcatheter closure is an alternative to surgical
treatment. In pediatric populations, few publications exist on the
feasibility and effectiveness of this treatment.
Aim.— To evaluate the feasibility of percutaneous closure of coro-
nary ﬁstulae in pediatrics, the evolution and the occurrence of
complications.
Methods.— Retrospective observational multicentric national study
concerning all patients under 16 who underwent transcatheter
closure of a congenital coronary ﬁstula (complex cardiopathies
excluded).
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Population.— Sixty-one patients (36 girls, 25 boys), median age
at diagnosis 0.6 years [0—15.4], 3,9 years at procedure [0—16].
Initial signs: precordial murmur (90%), congestive heart failure
(11%), nonspeciﬁc ECG abnormalities (4.9%), left or right ventri-
cular dilatation (31%). Efﬁciency: complete occlusion at hospital
discharge in 82%, ﬁve procedures failures. Complications: no death.
Three transient STEMI, three coil embolization, one ventricular
ﬁbrillation (recovered), one Leg ischemia. Combination therapy:
antiplatelet (46%), mean duration 4.1months. One with AVK treat-
ment then antiplatelet. Evolution: data are available for 43 children
(70%), median follow-up 91 days [min = 0, max = 4824]. At 2 years,
complete occlusion rate was 72.7%± 7.6%.
Five reoperations (three transcatheter, two surgical procedures).
One late recanalization at 17months.
No cardiovascular complication.
Conclusion.— Percutaneous closure of coronary ﬁstulas in the pedi-
atric population appears to be effective and relatively safe.
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Background.— The EDWARDS VALEO LIFESTENT® is a stainless steel,
premounted, open cell stent. Easy dilation to large diameters and
low proﬁle are advantages in growing children. Radial force is poor.
Methods and results.— Between 4-2011 and 12-2012, 41 VALEO®
stents were placed during 33 procedures, including 30 transcatheter
(group 1) and three peroperative procedures (group 2). Data
were retrospectively analyzed. Median age at implantation was
2.6 years (5 days—23 years), weight 10 kg (2—53). Indications were:
pulmonary artery stenosis (23), pulmonary vein stenosis (1), sub-
hepatic vein thrombosis (1), ductus arteriosus stenting (hybrid
approach) for hypoplastic left heart (6) and for interrupted aortic
arch (2).
In group 1, access was femoral in all except ﬁve (4 jugular, 1
transhepatic). Stent placement was achieved in all but one. Predi-
lation was performed in 14, postdilation in ﬁve. In group 2, stents
were placed during bypass, secured with a single stitch and ﬂared
at the proximal end. Acute complications were hemoptysis (3),
reperfusion edema (1), low cardiac output (2), stent dislodgement
(2) and fractures (2). Median follow-up (n = 28) reached 8.8 months
(1.9—34). Early recatheterization was performed in 19 patients
(median 5months). The stent was redilated in seven patients: three
(group 2) to achieve better wall apposition, one due to intimal
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